Etanercept

Key facts

Invented name
Enbrel
Active substance
etanercept
Therapeutic area
Dermatology
Decision number
P/241/2011
PIP number
Etanercept
Pharmaceutical form(s)
  • Powder and solvent for solution for injection
  • Powder for solution for injection
  • Powder and solvent for solution for injection for paediatric use
  • Solution for injection
Condition(s) / indication(s)
  • Juvenile idiopathic arthritis
  • Plaque psoriasis
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Wyeth Europa Limited
julian.britton@pfizer.com
United Kingdom
Phone: +44 1628692245
Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-000299-PIP01-08-M03
Compliance opinion date
13/12/2011
Compliance outcome
positive

Decision

How useful was this page?

Add your rating